Suppr超能文献

钠平衡及钠模式血液透析期间超滤模式组合对维持透析质量及钠和液体平衡的影响。

Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.

作者信息

Song Joon Ho, Park Geun Ho, Lee Sun Young, Lee Seung Won, Lee Seoung Woo, Kim Moon-Jae

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, Inha Kidney Disease Research Group, Inha University College of Medicine, Incheon, Korea.

出版信息

J Am Soc Nephrol. 2005 Jan;16(1):237-46. doi: 10.1681/ASN.2004070581. Epub 2004 Nov 24.

Abstract

Excessive sodium gain is a major hindrance of sodium profiling hemodialysis (HD) that offsets the benefit in reducing intradialytic hypotension-related discomforts (IHD). Patients who showed frequent IHD (>30% of the sessions; n = 11) were enrolled in a prospective study that consisted of two phases. In the phase 1 study, eight treatment modalities were evaluated: Conventional HD (control), sodium balance-positive step-down sodium profiling HD (PS), sodium balance-neutral step-down sodium profiling HD (NS), sodium balance-neutral alternating sodium profiling HD (NA) without ultrafiltration (UF) profile, and all those with UF profile (UF only, PS+U, NS+U, and NA+U). The incidences of "dialysis failure," defined as the occurrence of one or more of (1) session failure (discontinuation of session <75% of planned time), (2) UF failure (%UF achieved <70%), and (3) delivery failure (Kt/V <1.1), were 48.5, 21.2, 42.4, 39.4, 45.5, 18.2, 21.2, and 18.2% in control, PS, NS, NA, UF only, PS+U, NS+U, and NA+U, respectively. Four treatments, PS, PS+U, NS+U, and NA+U, reduced the incidence of dialysis failure significantly as compared with control (P < 0.05) and were evaluated in the phase 2 study, a randomized controlled 6-wk crossover study. Parameters were measured in the steady state after a 6-wk maintenance of each treatment. Diffusive sodium gain (DeltaNa) was significantly increased with sodium balance-positive profiles with or without UF profile, PS and PS+U (PS 1.9 +/- 1.1, PS+U 1.7 +/- 1.0 mEq/L; both P < 0.05 to control -0.1 +/- 0.2, NS+U 0.5 +/- 0.4, NA+U 0.4 +/- 0.2 mEq/L). They also increased the interdialytic weight gain (PS 3.8 +/- 0.6, PS+U 4.0 +/- 0.6 kg; both P < 0.05 to control 2.7 +/- 0.6, NS+U 3.3 +/- 0.6 kg; both P = NS to NA+U 3.5 +/- 0.6 kg). Predialysis weight and the required amount of UF also increased significantly with these sodium balance-positive profiles. Although the absolute amount of UF was larger with PS and PS+U, %UF achieved targeting dry weight was higher with sodium balance-neutral profiles with UF profiles, NS+U and NA+U (NS+U 92.7 +/- 3.8, NA+U 93.7 +/- 6.8%; both P < 0.05 to control 72.6 +/- 14.0, PS 88.3 +/- 6.6, PS+U 88.2 +/- 8.2%). Postdialysis weight was closest to dry weight with these treatments showing Delta (postdialysis weight - dry weight) of 0.3 +/- 0.1 and 0.3 +/- 0.2 kg in NS+U and NA+U (both P < 0.05 to control 1.0 +/- 0.6 kg; both P = NS to PS 0.5 +/- 0.3, PS+U 0.5 +/- 0.4 kg). Incidence of excessive weight gain and subjective discomforts during the interdialytic period increased significantly with PS. In conclusion, continuous use of sodium balance-positive sodium profiles resulted in an undesirable steady state with sodium and fluid expansion offsetting their hemodynamic benefit. Sodium balance-neutral sodium profiles in combination with UF profile were associated with less sodium and weight gains, better UF performance with postdialysis weight closest to dry weight, and fewer interdialytic problems with the equivalent hemodynamic benefit. Therefore, it is proposed that sodium balance-neutral sodium profiling HD with UF profile is a better choice, ensuring the dialysis of quality without sodium gain-related complications.

摘要

钠摄入过多是钠曲线轮廓血液透析(HD)的主要障碍,它抵消了减少透析中低血压相关不适(IHD)的益处。将频繁出现IHD(>30%的透析次数;n = 11)的患者纳入一项前瞻性研究,该研究包括两个阶段。在1期研究中,评估了八种治疗模式:常规HD(对照)、钠平衡正向递减钠曲线轮廓HD(PS)、钠平衡中性递减钠曲线轮廓HD(NS)、无超滤(UF)曲线的钠平衡中性交替钠曲线轮廓HD(NA),以及所有带有UF曲线的模式(仅UF、PS+U、NS+U和NA+U)。“透析失败”的发生率定义为出现以下一种或多种情况:(1)透析失败(透析疗程中断<计划时间的75%)、(2)超滤失败(实现的超滤率<70%)和(3)透析剂量失败(Kt/V<1.1),在对照、PS、NS、NA、仅UF、PS+U、NS+U和NA+U组中分别为48.5%、21.2%、42.4%、39.4%、45.5%、18.2%、21.2%和18.2%。与对照相比,PS、PS+U、NS+U和NA+U这四种治疗显著降低了透析失败的发生率(P<0.05),并在2期研究中进行了评估,这是一项为期6周的随机对照交叉研究。在每种治疗维持6周后的稳态下测量参数。无论有无UF曲线,钠平衡正向曲线的扩散性钠增加量(ΔNa)显著增加,PS和PS+U组(PS 1.9±1.1,PS+U 1.7±1.0 mEq/L;两者与对照-0.1±0.2、NS+U 0.5±0.4、NA+U 0.4±0.2 mEq/L相比,P均<0.05)。它们还增加了透析间期体重增加(PS 3.8±0.6 kg,PS+U 4.0±0.6 kg;两者与对照2.7±0.6 kg相比,P均<0.05;两者与NA+U 3.5±0.6 kg相比,P均=NS)。这些钠平衡正向曲线也使透析前体重和所需超滤量显著增加。虽然PS和PS+U组的绝对超滤量更大,但带有UF曲线的钠平衡中性曲线NS+U和NA+U组实现目标干体重的超滤率更高(NS+U 92.7±3.8%,NA+U 93.7±6.8%;两者与对照72.6±14.0%、PS 88.3±6.6%、PS+U 88.2±8.2%相比,P均<0.05)。NS+U和NA+U组透析后体重最接近干体重,透析后体重与干体重的差值(Δ)分别为0.3±0.1 kg和0.3±0.2 kg(两者与对照1.0±0.6 kg相比,P均<0.05;两者与PS 0.5±0.3 kg、PS+U组0.5±0.4 kg相比,P均=NS)。PS组透析间期体重过度增加和主观不适的发生率显著增加。总之,持续使用钠平衡正向钠曲线会导致不理想的稳态,钠和液体潴留抵消了它们的血流动力学益处。钠平衡中性钠曲线与UF曲线相结合,钠和体重增加较少,超滤性能更好,透析后体重最接近干体重,透析间期问题较少,且具有同等的血流动力学益处。因此,建议采用带有UF曲线的钠平衡中性钠曲线轮廓HD是更好的选择,可确保高质量透析且无钠摄入相关并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验